FDA Drug recall D-0285-2022
Telmisartan and Hydrochlorothiazide Tablets, USP, 40 mg/12.5 mg, 30 count bottles, Rx only, Manufactured by: Torrent Pharmaceuticals LTD.,…
- FDA Drug
- Class III
- terminated
- Published 2021-12-22
On 2021-12-22 the FDA classified a Class III recall of Telmisartan and Hydrochlorothiazide Tablets, USP, 40 mg/12.5 mg, 30 count bottles, Rx only, Manufactured by: Torrent Pharmaceuticals LTD.,… by Torrent Pharma, citing superpotent; Hydrochlorothiazide.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0285-2022 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2021-12-01 |
| Published | 2021-12-22 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Torrent Pharma |
| Distribution | US |
Product
Telmisartan and Hydrochlorothiazide Tablets, USP, 40 mg/12.5 mg, 30 count bottles, Rx only, Manufactured by: Torrent Pharmaceuticals LTD., Indrad-382 721, India. Manufactured for: Torrent Pharma Inc., Basking Ridge, NJ 07920. NDC: 13668-159-30
Reason
Superpotent; Hydrochlorothiazide
Identifiers
| code_info | Batch: BZ74G001 Exp. 12/2021. |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0285-2022%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.